Credit Suisse’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-24
| Closed | – | – | 4456 |
|
|
2022
Q2 | $0 | Sell |
24
-28,593
| -100% | – | ﹤0.01% | 4523 |
|
|
2022
Q1 | $158K | Buy |
28,617
+1,743
| +6% | +$9.62K | ﹤0.01% | 3407 |
|
|
2021
Q4 | $259K | Buy |
26,874
+1,091
| +4% | +$10.5K | ﹤0.01% | 3355 |
|
|
2021
Q3 | $461K | Buy |
25,783
+1,553
| +6% | +$27.8K | ﹤0.01% | 3039 |
|
|
2021
Q2 | $592K | Buy |
24,230
+3,999
| +20% | +$97.7K | ﹤0.01% | 2931 |
|
|
2021
Q1 | $536K | Sell |
20,231
-11,440
| -36% | -$303K | ﹤0.01% | 2914 |
|
|
2020
Q4 | $240K | Buy |
31,671
+14,746
| +87% | +$112K | ﹤0.01% | 3198 |
|
|
2020
Q3 | $84K | Sell |
16,925
-3,197
| -16% | -$15.9K | ﹤0.01% | 3177 |
|
|
2020
Q2 | $121K | Buy |
20,122
+4,130
| +26% | +$24.8K | ﹤0.01% | 3176 |
|
|
2020
Q1 | $71K | Sell |
15,992
-469
| -3% | -$2.08K | ﹤0.01% | 3262 |
|
|
2019
Q4 | $156K | Sell |
16,461
-5,357
| -25% | -$50.8K | ﹤0.01% | 3360 |
|
|
2019
Q3 | $171K | Buy |
21,818
+4,690
| +27% | +$36.8K | ﹤0.01% | 3228 |
|
|
2019
Q2 | $269K | Buy |
+17,128
| New | +$269K | ﹤0.01% | 3098 |
|